Novartis investigational multiple sclerosis therapy Gilenia(R)* (FTY720) shown ... - Trading Markets (press release)

Submitted by Google Search on


Novartis investigational multiple sclerosis therapy Gilenia(R)* (FTY720) shown ...
Trading Markets (press release)
Oral Fingolimod (FTY720) vs Placebo in Relapsing-Remitting Multiple Sclerosis: 24-month Clinical Efficacy Results from a Randomized, Double-Blind, ...
Novartis moves closer to first oral MS treatmentReuters

all 13 news articles »

Add new comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Filtered HTML

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.